Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790242 · ClinicalTrials.gov registry record
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 1,089
- Enrollment target
NCT02790242: Clinical Trial study, sponsored by Columbia University.
NCT02790242 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 1,089 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02790242 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 1,089 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on patients who have heart failure and are eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular assist device (VAD) or 2) heart transplant. the study seeks to determine which patient populations benefit from heart transplant or ventricular assist device. This will allow to offer the state-of-the-art care to the patients in heart failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,089 participants |
| Start Date | 2013-11 |
| Est. Completion | 2020-02-11 |
Why NCT02790242 stopped before completion
NCT02790242 is an observational study that tracks outcomes without assigning an intervention. Its 1,089 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02790242 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02790242 about?
NCT02790242 is a clinical study titled "Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy". The purpose of this study is to gather information on patients who have heart failure and are eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular assist device (VAD) or 2) heart transplant. the study seeks to determine which patient populations benefit from hear...
What is the current status of trial NCT02790242?
This trial is currently terminated. The enrollment target is 1,089 participants. The study started on 2013-11. Estimated completion is 2020-02-11.
Who is sponsoring clinical trial NCT02790242?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06671483 · 1,088 participants · Phase 3
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- NCT07196722 · 1,092 participants · Phase 2
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- NCT03754114 · 1,094 participants · NA
Brain Oxygen Optimization in Severe TBI, Phase 3
- NCT06118983 · 1,094 participants · NA
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia